IONIS-MAPTRx

After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease
BioSpace
Thu, 12/19/19 - 01:04 pm
Biogen
Alzheimer's disease
IONIS-MAPTRx
Ionis Pharmaceuticals
Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
GoinPharma
Mon, 10/16/17 - 09:37 pm
Alzheimer's disease
Ionis Pharmaceuticals
IONIS-MAPTRx
antisense